Aetiology, management, and outcomes of eosinophilic pleural effusion: data from the International Multicentre Pleural Research Collaborative
Authors:
- Rafal KrenkeRKRafal Krenke
- Magdalena E. GrabczakMGMagdalena E. Grabczak
- Jordy KerkhoffJKJordy Kerkhoff
- Silvia BielsaSBSilvia Bielsa
- José M. PorcelJPJosé M. Porcel
- Mateja Marc-MalovrhMMMateja Marc-Malovrh
- Ales RozmanARAles Rozman
- Michael A. MitchellMMMichael A. Mitchell
- Katarzyna FaberKFKatarzyna Faber
- Stavros AnevlavisSAStavros Anevlavis
- Avinash AuyayebAAAvinash Auyayeb
- Uffe BodtgerUBUffe Bodtger
Open Access
- 12 March 2026
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Abstract
Background: Eosinophilic pleural effusion (EPE) is a relatively uncommon condition. The objective of this study was to evaluate the clinical, laboratory, and radiological features of EPE in a multicentre cohort of patients. Methods: This retrospective study included patients with EPE, defined as pleural fluid in which eosinophils constitute ≥10% of the total nucleated cell count, treated between 2009 and 2021 at eight respiratory centres. Predefined data were collected in the International Multicentre Pleural Research Collaborative (IMPACT) registry. Results: The study included 210 patients (144 [68.6%] males), with a median age of 67 years (IQR 55–78). Radiological evaluation showed unilateral effusion in 194 (94.2%) patients. Most EPEs (199; 95.7%) were exudates. The median pleural fluid eosinophil percentage was 23% (IQR 14.8–43.3%). The most common aetiologies were malignancy 61 (29%), infection 43 (20.5%), heart diseases/cardiac intervention 17 (8.1%), or trauma 16 (7.6%). In 42 (20%) patients, the cause of EPE remained undetermined. In univariate and multivariable analyses incorporating available clinical and laboratory data, EPE was not a significant predictor of either malignancy or benign disease. Conclusion: Eosinophilic pleural effusion is a non-specific diagnostic entity and should not, by itself, be regarded as a relevant factor in clinical decision-making.Keywords
This publication has 28 references indexed in Scilit:
- CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosisnpj Precision Oncology, 2024
- Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapyNature Immunology, 2022
- Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusionCancer Immunology, Immunotherapy, 2021
- A new dawn for eosinophils in the tumour microenvironmentNature Reviews Cancer, 2020
- Derrames pleurales eosinofílicos: incidencia, etiología y significado pronósticoArchivos de Bronconeumología, 2011
- Pleural Fluid and Peripheral Eosinophilia from Hemothorax: Hypothesis of the Pathogenesis of EPE in Hemothorax and PneumothoraxThe American Journal of the Medical Sciences, 2006
- Pathogenesis of the eosinophilic pleural effusionsCurrent Opinion in Pulmonary Medicine, 2004
- Eosinophilic pleural effusionsCurrent Opinion in Pulmonary Medicine, 2003
- Analysis of pleural fluid in idiopathic spontaneous pneumothorax; correlation of eosinophil percentage with the duration of air in the pleural spaceRespiratory Medicine, 1999
- Diagnostic utility of pleural fluid eosinophiliaThe American Journal of Medicine, 1984